Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Nephrology

Standard of Care Treatment and Day-to-Day Management

At a Glance

Fanconi renotubular syndrome 1 is managed with individualized phosphate, active vitamin D, bicarbonate or citrate, and potassium when needed. Regular blood, urine, kidney ultrasound, and growth checks help protect bone and kidney health, but treatment does not correct the underlying GATM mutation.

Managing Fanconi Renotubular Syndrome 1 (FRTS1) is often described as a “tightrope walk.” Because your kidneys are constantly losing vital minerals, the goal of treatment is to refill the body’s tank without overfilling it, which can cause its own set of problems [1][2]. Currently, there is no “cure” that stops the GATM mutation from causing damage, so care focuses on supporting the body and preventing complications like rickets [3][4].

Clinician-Directed Treatment Options

Since FRTS1 causes the kidneys to “leak,” doctors use a combination of supplements to replace what is lost based on individualized labs. This supportive care is highly individualized; what works for one person may be too much or too little for another [1][2]. Do not start, stop, or change the dose of these supplements without your treating team’s direction, as over-replacement can harm the kidneys.

  • Phosphate Salts: These are usually taken several times a day to maintain bone strength and prevent rickets [1]. Because phosphate can be hard on the stomach, it is often split into multiple small doses [5].
  • Active Vitamin D (Calcitriol/Alfacalcidol): Unlike standard Vitamin D, these “active” forms help the body absorb the phosphate you are taking [1][6]. Not everyone requires this, and it must be monitored carefully.
  • Alkali Therapy (Bicarbonate/Citrate): If the blood becomes too acidic (metabolic acidosis), doctors prescribe oral bicarbonate or citrate to restore balance [7][8].
  • Potassium: If the kidneys are leaking potassium, supplements are used to prevent muscle weakness and heart rhythm issues [9][7].

The Tightrope Walk: Benefits vs. Risks

Every medication used in FRTS1 requires careful balancing. Doctors monitor several “risk zones” to ensure the treatment isn’t causing new damage [1][2].

  • Nephrocalcinosis: This is the buildup of calcium in the kidney tissue [10]. It can happen if the balance between phosphate and Vitamin D isn’t quite right, leading to too much calcium in the urine (hypercalciuria) [11][1].
  • Secondary Hyperparathyroidism: If phosphate levels are replaced without enough active Vitamin D, the parathyroid glands can become overactive, which ironically pulls more calcium out of the bones [1][2].
  • Gastrointestinal Distress: High doses of oral phosphate can cause diarrhea, stomach cramps, or nausea [5][1]. If this happens, your doctor may adjust the dose or timing.

Monitoring and “Scan Anxiety”

Because the balance can shift as a child grows, regular monitoring is the most important part of day-to-day management.

  • Blood and Urine Labs: Expect frequent checks of kidney function (eGFR), phosphate, calcium, potassium, bicarbonate, and alkaline phosphatase (a marker of bone health) [1][2].
  • Imaging: Periodic kidney ultrasounds are used to look for calcium deposits (nephrocalcinosis), and X-rays may be used to check how rickets are healing [10][2].
  • Growth Tracking: Doctors will closely monitor height and leg alignment to ensure the treatment is protecting the skeleton [2][1].

It is natural to feel anxious before these appointments. Many families find it helpful to keep a dedicated folder or app to track lab trends, which can provide a sense of control over the data [12].

The Future: GATM-Specific Research

Currently, there is no validated treatment that targets the GATM mutation itself [3]. However, researchers are exploring creatine supplementation as a possible way to reduce the production of the faulty protein [13].

  • Status: This research is in very early stages (pre-clinical or small animal/cell studies) [13][14]. It is not an established treatment in humans.
  • Caution: You should not start creatine or any other supplement without direct supervision from your nephrologist, as it could artificially raise your serum creatinine levels or interfere with kidney function tests [13].

While the daily burden of supplements and testing is high, this consistent care is the best way to protect bone health while waiting for more targeted therapies to emerge [1][3].

Common questions in this guide

What treatments are used to manage FRTS1?
FRTS1 is managed with supportive treatment rather than a cure. A care team may prescribe phosphate salts, active vitamin D, bicarbonate or citrate for excess acidity, and potassium when laboratory results show it is needed.
Why does my child need frequent blood and urine tests for FRTS1?
Testing helps the care team track kidney function, phosphate, calcium, potassium, bicarbonate, alkaline phosphatase, and urine calcium. Results guide supplement changes and help identify treatment problems before they harm the kidneys or bones.
What are the main risks of phosphate and active vitamin D treatment?
Too much replacement can increase calcium in the urine and contribute to calcium deposits in the kidneys, called nephrocalcinosis. Phosphate can also cause diarrhea, cramps, or nausea, while an imbalance between phosphate and active vitamin D can contribute to overactive parathyroid glands.
What should we do if my child cannot keep the supplements down?
Ask the nephrology team for a sick-day plan before an illness occurs. If vomiting or diarrhea prevents your child from taking or absorbing supplements, contact the care team for individualized instructions rather than changing or restarting doses on your own.
Is creatine an established treatment for FRTS1?
No. Creatine is being studied in early laboratory and animal research, but it is not an established treatment for people with FRTS1. Do not start it without the nephrologist's guidance because it may raise blood creatinine or interfere with kidney function testing.
How is bone and kidney health monitored in FRTS1?
Clinicians may follow blood and urine tests, growth and leg alignment, kidney ultrasounds, and X-rays when needed. These checks help assess bone healing and look for kidney calcium deposits as a child grows.

Get notified when new evidence is published on Fanconi renotubular syndrome 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  2. 2

    Management of bone disease in cystinosis: Statement from an international conference.

    Hohenfellner K, Rauch F, Ariceta G, et al.

    Journal of inherited metabolic disease 2019; (42(5)):1019-1029 doi:10.1002/jimd.12134.

    PMID: 31177550
  3. 3

    Genetic Screening of Patients With Inherited Fanconi Syndrome.

    Inoki Y, Sakakibara N, Yamamoto A, et al.

    Kidney international reports 2026; (11(7)):106576 doi:10.1016/j.ekir.2026.106576.

    PMID: 42282999
  4. 4

    Complex phenotype in Fanconi renotubular syndrome type 1: Hypophosphatemic rickets as the predominant presentation.

    Li CY, Sun Y, Guo WC, et al.

    Clinica chimica acta; international journal of clinical chemistry 2024; (561()):119812 doi:10.1016/j.cca.2024.119812.

    PMID: 38876250
  5. 5

    Management of patients with X-linked hypophosphatemic rickets during Covid-19 pandemic lockdown.

    Baroncelli GI, Bertelloni S, Cosci O Di Coscio M, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(7)):905-910 doi:10.1515/jpem-2021-0217.

    PMID: 33887813
  6. 6

    An Overview of Rickets in Children.

    Chanchlani R, Nemer P, Sinha R, et al.

    Kidney international reports 2020; (5(7)):980-990 doi:10.1016/j.ekir.2020.03.025.

    PMID: 32647755
  7. 7

    Rickets in proximal renal tubular acidosis: a case series of six distinct etiologies.

    Singhania P, Dhar A, Deshpande A, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(9)):879-885 doi:10.1515/jpem-2023-0155.

    PMID: 37434360
  8. 8

    Renal Tubular Acidosis and Management Strategies: A Narrative Review.

    Palmer BF, Kelepouris E, Clegg DJ

    Advances in therapy 2021; (38(2)):949-968 doi:10.1007/s12325-020-01587-5.

    PMID: 33367987
  9. 9

    Successful Management of Refractory Type 1 Renal Tubular Acidosis with Amiloride.

    Oguejiofor P, Chow R, Yim K, Jaar BG

    Case reports in nephrology 2017; (2017()):8596169 doi:10.1155/2017/8596169.

    PMID: 28127482
  10. 10

    Skeletal Consequences of Nephropathic Cystinosis.

    Florenzano P, Ferreira C, Nesterova G, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018; (33(10)):1870-1880 doi:10.1002/jbmr.3522.

    PMID: 29905968
  11. 11

    Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets.

    Keskin M, Savaş-Erdeve Ş, Sağsak E, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2015; (28(11-12)):1333-7.

    PMID: 26203600
  12. 12

    Genetic Testing in the Pediatric Nephrology Clinic: Understanding Families' Experiences.

    Nevin SM, McLoone J, Wakefield CE, et al.

    Journal of pediatric genetics 2022; (11(2)):117-125 doi:10.1055/s-0040-1721439.

    PMID: 35769952
  13. 13

    Reduced guanidinoacetate in plasma of patients with autosomal dominant Fanconi syndrome due to heterozygous P341L GATM variant and study of organoids towards treatment.

    Portales-Castillo I, Singal R, Ambrose A, et al.

    JIMD reports 2024; (65(5)):341-353 doi:10.1002/jmd2.12442.

    PMID: 39544690
  14. 14

    Distinct Mitochondrial Pathologies Caused by Mutations of the Proximal Tubular Enzymes EHHADH and GATM.

    Forst AL, Reichold M, Kleta R, Warth R

    Frontiers in physiology 2021; (12()):715485 doi:10.3389/fphys.2021.715485.

    PMID: 34349672

This page is for informational purposes only and does not constitute medical advice. A nephrologist should tailor your child's supplements, monitoring, and sick-day plan; do not change treatment without the care team's guidance.